Kriya Therapeutics

company

About

Kriya Therapeutics is a gene therapy company designing and developing transformative new treatments for a broad range of diseases.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$100M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2019
Number Of Employee
101 - 250
Operating Status
Active

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$450.50M
Kriya Therapeutics has raised a total of $450.50M in funding over 2 rounds. Their latest funding was raised on May 16, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 16, 2022 Series C $270M 1 Detail
Jul 14, 2021 Series B $100M 2 Detail
May 12, 2020 Series A $80.50M 1 Detail
Oct 1, 2019 Seed 1 Transhuman Capital Detail

Investments

Number of Investments
Number of Lead Investments
3
1
Kriya Therapeutics has made 3 investments. Their most recent investment was on Jul 7, 2022, when HATCH raised $1.15M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 7, 2022 HATCH
Pre-seed $1.15M Artificial Intelligence
Apr 6, 2016 Numerai
Series Unknown $7.50M Artificial Intelligence Yes
Oct 6, 2014 Augury
Seed $2M Analytics

Investors

Number of Lead Investors
Number of Investors
1
2
Kriya Therapeutics is funded by 2 investors. Transhuman Capital and Hongkou are the most recent investors.
Investor Name Lead Investor Funding Round
Transhuman Capital Series C
Hongkou Series B